| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1037433076 |
| P356 | DOI | 10.1186/1479-7364-7-24 |
| P932 | PMC publication ID | 4174666 |
| P698 | PubMed publication ID | 24283712 |
| P5875 | ResearchGate publication ID | 258956980 |
| P50 | author | Shuotun Zhu | Q114446875 |
| Lynnette Ferguson | Q42368330 | ||
| Nishi Karunasinghe | Q59680589 | ||
| Alan Fraser | Q89301002 | ||
| Gareth Marlow | Q58825885 | ||
| P2093 | author name string | Dug Yeo Han | |
| Stephanie Ellett | |||
| Amalini C Jesuthasan | |||
| Isobel R Ferguson | |||
| P2860 | cites work | The human intestinal microbiome: a new frontier of human biology | Q24649671 |
| Gene expression of peripheral blood mononuclear cells as a tool in dietary intervention studies: What do we know so far? | Q38011660 | ||
| Intestinal microbiota is a plastic factor responding to environmental changes | Q38016621 | ||
| Nutritional and probiotic supplementation in colitis models | Q38021933 | ||
| IRF-2 regulates NF-kappaB activity by modulating the subcellular localization of NF-kappaB. | Q39994340 | ||
| The cytokinesis-block micronucleus technique: A detailed description of the method and its application to genotoxicity studies in human populations | Q40484317 | ||
| Sensitivity to five mutagens in Fanconi's anemia as measured by the micronucleus method | Q43685809 | ||
| Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease | Q73802538 | ||
| Dietary patterns and risk for Crohn's disease in children | Q80230030 | ||
| Transcriptional activity of genes encoding interferon gamma (IFNgamma) and its receptor assessed in peripheral blood mononuclear cells in patients with cardiac syndrome X | Q80423687 | ||
| The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease | Q80630872 | ||
| The molecular biology of inflammatory bowel diseases | Q84591704 | ||
| Captopril enhances transforming growth factor (TGF)-beta1 expression in peripheral blood mononuclear cells: a mechanism independent from angiotensin converting enzyme inhibition? A study in cyclosporine-treated kidney-transplanted patients | Q44260920 | ||
| Dietary factors in chronic inflammation: food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population | Q44557237 | ||
| Consumption of oat beta-glucan with or without plant stanols did not influence inflammatory markers in hypercholesterolemic subjects | Q46268207 | ||
| An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. | Q50562039 | ||
| Effects of a supplementation of n-3 polyunsaturated fatty acids with or without fish gelatin on gene expression in peripheral blood mononuclear cells in obese, insulin-resistant subjects. | Q51536301 | ||
| Cytokinesis-block micronucleus cytome assay in lymphocytes | Q53290705 | ||
| Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. | Q53774306 | ||
| Validation of the use of peripheral blood mononuclear cells as surrogate model for skeletal muscle tissue in nutrigenomic studies. | Q53867223 | ||
| Effect of a traditional Mediterranean diet on apolipoproteins B, A-I, and their ratio: A randomized, controlled trial | Q58419605 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases | Q28131810 | ||
| Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach | Q29617547 | ||
| Nutritional systems biology modeling: from molecular mechanisms to physiology | Q30943969 | ||
| The human peripheral blood mononuclear cell proteome responds to a dietary flaxseed-intervention and proteins identified suggest a protective effect in atherosclerosis | Q33294637 | ||
| Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults | Q33464636 | ||
| High taxonomic level fingerprint of the human intestinal microbiota by ligase detection reaction--universal array approach | Q33557927 | ||
| Specialized pro-resolving lipid mediators in the inflammatory response: An update | Q33657562 | ||
| Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. | Q34017980 | ||
| The resolution of inflammation: the devil in the flask and in the details | Q34181437 | ||
| Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease | Q34241773 | ||
| Unbalance of intestinal microbiota in atopic children | Q34294318 | ||
| Effects of exercise on gene expression in human peripheral blood mononuclear cells | Q34326727 | ||
| Long-term effect of mediterranean-style diet and calorie restriction on biomarkers of longevity and oxidative stress in overweight men | Q34442801 | ||
| The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. | Q34627475 | ||
| Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease | Q36250322 | ||
| Gene expression profiling in peripheral blood leukocytes as a new approach for assessment of human stress response | Q36259294 | ||
| Analysis of bacterial bowel communities of IBD patients: what has it revealed? | Q37084765 | ||
| Role of STAT3 in inflammatory bowel disease | Q37262986 | ||
| Food and the gut microbiota in inflammatory bowel diseases: a critical connection | Q37292450 | ||
| C-reactive protein is a mediator of cardiovascular disease | Q37777888 | ||
| Mediterranean diet and weight loss: meta-analysis of randomized controlled trials. | Q37802884 | ||
| Diet in inflammatory bowel disease | Q37859176 | ||
| Fatty acids and inflammation: the cutting edge between food and pharma. | Q37911577 | ||
| Nutritional biomarkers and foodomic methodologies for qualitative and quantitative analysis of bioactive ingredients in dietary intervention studies. | Q37932099 | ||
| New insights into the role of STAT3 in IBD. | Q37945139 | ||
| Potential value of nutrigenomics in Crohn's disease | Q37992788 | ||
| Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases | Q38001977 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| affy | Q113334509 | ||
| P921 | main subject | patient | Q181600 |
| Crohn's disease | Q1472 | ||
| inflammation | Q101991 | ||
| transcriptome | Q252857 | ||
| transcriptomics | Q28946449 | ||
| P304 | page(s) | 24 | |
| P577 | publication date | 2013-11-27 | |
| P1433 | published in | Human genomics | Q26842690 |
| P1476 | title | Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients | |
| P478 | volume | 7 |
| Q64067021 | A Pilot Low-Inflammatory Dietary Intervention to Reduce Inflammation and Improve Quality of Life in Patients With Familial Adenomatous Polyposis: Protocol Description and Preliminary Results |
| Q35824866 | A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet |
| Q38804294 | A quinazoline-based HDAC inhibitor affects gene expression pathways involved in cholesterol biosynthesis and mevalonate in prostate cancer cells. |
| Q53971248 | A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity. |
| Q43364575 | Adherence to the Mediterranean diet is associated with the gut microbiota pattern and gastrointestinal characteristics in an adult population. |
| Q28069172 | Advances in Integrating Traditional and Omic Biomarkers When Analyzing the Effects of the Mediterranean Diet Intervention in Cardiovascular Prevention |
| Q36114884 | Alzheimer's disease and gut microbiota |
| Q37729775 | An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease |
| Q90481244 | Association Between Mediterranean Anti-inflammatory Dietary Profile and Severity of Psoriasis: Results From the NutriNet-Santé Cohort |
| Q26801620 | Cholesterol confusion and statin controversy |
| Q50629310 | Chromosomal DNA damage measured using the cytokinesis-block micronucleus cytome assay is significantly associated with cognitive impairment in South Australians. |
| Q92227360 | Diet and inflammatory bowel disease: The Asian Working Group guidelines |
| Q40059675 | Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention |
| Q93018275 | Dietary Support in Elderly Patients with Inflammatory Bowel Disease |
| Q34775051 | Dysbiotic events in gut microbiota: impact on human health |
| Q92990866 | Effects of Fish n-3 PUFAs on Intestinal Microbiota and Immune System |
| Q26739934 | Evidence to Support the Anti-Cancer Effect of Olive Leaf Extract and Future Directions |
| Q39004831 | Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry |
| Q60727568 | Food for thought: The role of nutrition in the microbiota-gut–brain axis |
| Q55393177 | Gut Microbiome Composition in Non-human Primates Consuming a Western or Mediterranean Diet. |
| Q35602080 | Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain. |
| Q35791181 | High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome |
| Q35996428 | Human microbiome versus food-borne pathogens: friend or foe. |
| Q64067682 | Hydroxytyrosol Improves Obesity and Insulin Resistance by Modulating Gut Microbiota in High-Fat Diet-Induced Obese Mice |
| Q35575495 | IBD and the gut microbiota--from bench to personalized medicine |
| Q93385892 | Impact of Small Intestine Bacterial Overgrowth on Response to a Nutritional Intervention in Bangladeshi Children from an Urban Community |
| Q59799367 | Impact of a Healthy Dietary Pattern on Gut Microbiota and Systemic Inflammation in Humans |
| Q47104184 | Mediterranean Diet: Prevention of Colorectal Cancer |
| Q26829951 | Mediterranean diet and health: food effects on gut microbiota and disease control |
| Q46723510 | Mediterranean diet: the missing link between gut microbiota and inflammatory diseases |
| Q61812628 | Metabolomics and Microbiomes as Potential Tools to Evaluate the Effects of the Mediterranean Diet |
| Q26750985 | Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients |
| Q90674599 | Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance |
| Q26781298 | Nutritional Modulation of Gene Expression: Might This be of Benefit to Individuals with Crohn's Disease? |
| Q92567843 | Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial |
| Q64098968 | Prebiotic supplementation in frail older people affects specific gut microbiota taxa but not global diversity |
| Q47923338 | Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO]. |
| Q39082805 | The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease |
| Q30234868 | The Role of Diet in Inflammatory Bowel Disease |
| Q28075770 | The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood |
| Q64900045 | The role of diet in the prevention and treatment of Inflammatory Bowel Diseases. |
| Q33749384 | Transcriptomics and the Mediterranean Diet: A Systematic Review |
| Q26777054 | Whole-Blood Gene Expression Profiles in Large-Scale Epidemiological Studies: What Do They Tell? |
| Q28073732 | Why Are Omics Technologies Important to Understanding the Role of Nutrition in Inflammatory Bowel Diseases? |
Search more.